Inventor · Seattle, WA, US

Ling Wang

35Patents
7h-index
85Co-inventors
72Inventor score

Filing activity: Jun 7, 1995 → Jun 1, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6379897B1 Methods for gene expression monitoring on electronic microarrays Electricity 59 Expired
US8809530B1 Compositions of protein receptor tyrosine kinase inhibitors Chemistry; Metallurgy 32 Active
US5925529A Method for discovery of peptide agonists Physics 18 Expired
US6492122B2 Quantitative analysis methods on active electronic microarrays Electricity 18 Expired
US6468742B2 Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip Electricity 13 Expired
US7625555B2 Recombinant human interferon-like proteins Human Necessities 9 Active
US8999992B2 Crystalline forms of tryosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 7 Active
US9040508B2 Compositions of protein receptor tyrosine kinase inhibitors Chemistry; Metallurgy 7 Active
US9388146B2 Crystalline forms of tyrosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 6 Active
US8425895B2 Recombinant human interferon-like proteins Human Necessities 4 Active
US9234022B2 Recombinant human interferon-like proteins and method of treatment using them Human Necessities 3 Active
US7868151B2 Recombinant human interferon-like proteins Human Necessities 3 Active
US7867482B2 Recombinant human interferon-like proteins Human Necessities 3 Active
US9718794B2 Crystalline forms of tyrosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 3 Active
US9738659B2 Compositions of protein receptor tyrosine kinase inhibitors Chemistry; Metallurgy 3 Active
US10124002B2 Crystalline forms of tyrosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 2 Active
US9993473B2 Crystalline forms of tyrosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 2 Active
US7582421B2 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip Emerging Cross-Sectional Technologies 1 Expired
US10421763B2 Compositions of protein receptor tyrosine kinase inhibitors Chemistry; Metallurgy 0 Active
US11739382B2 Compositions and methods for amplification and detection of hepatitis B virus RNA, including HBV RNA transcribed from cccDNA Chemistry; Metallurgy 0 Active
US10301271B2 Crystalline forms of tyrosine kinase inhibitors and their salts Emerging Cross-Sectional Technologies 0 Active
US12016923B2 Claudin 18.2 T cell-antigen couplers and uses thereof Chemistry; Metallurgy 0 Active
US9138439B2 Methods and compositions for modulating P300/CBP activity Emerging Cross-Sectional Technologies 0 Active
US11377497B2 PD-L1 binding polypeptide or composite Chemistry; Metallurgy 0 Active
US9982028B2 Recombinant human interferon-like proteins Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.